Tag: Moderna

Canada approves Moderna shot targeting Omicron

OTTAWA, Canada (AFP) – Canada on Thursday authorized an updated Moderna Covid-19 booster shot that specifically targets the Omicron variant and is said to provide significantly better protection against it. In a summary of the decision, Health Canada said clinical trials of the new bivalent vaccine induced significantly higher immune responses than its predecessor against the now dominant Omicron variants. It also matched the older Moderna vaccine’s effectiveness against the original virus, and is recommended […]

Continue Reading →

Moderna sues Pfizer, BioNTech over Covid vaccine

  by Joshua Melvin with Juliette Michel in New York Agence France Presse Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot administered to hundreds of millions around the world. The lawsuits set up a high-stakes showdown between the leading manufacturers of Covid-19 shots that are a key tool in the fight against the disease. “Moderna believes that Pfizer and […]

Continue Reading →

UK clears new Moderna vaccine targeting Omicron variant

  LONDON, United Kingdom (AFP) — The UK’s drug regulator said Monday it had approved an updated Moderna vaccine against Covid-19 that targets the Omicron variant as well as the original form of the virus. The Medicine and Healthcare products Regulatory Agency (MHRA) said in a statement said it had approved the vaccine for adult booster doses “after it was found to meet the UK regulator’s standards of safety, quality and effectiveness”. It was the […]

Continue Reading →

Southern hemisphere to get first mRNA vaccine facility

SYDNEY, Australia (AFP) – Covid-19 vaccine maker Moderna announced Monday that it will open an mRNA vaccine manufacturing facility in the Australian city of Melbourne, a first for the southern hemisphere. The project will be based at one of Australia’s largest universities, Monash, and will produce 100 million vaccine doses a year for Covid-19, influenza and other diseases. Moderna’s Spikevax was one of a new class of inoculations developed during the coronavirus pandemic that uses […]

Continue Reading →

US approves Pfizer and Moderna vaccines for youngest children

  WASHINGTON, United States (AFP) — The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries. The agency, whose approval is considered the global gold standard, authorized Moderna’s two-dose vaccine for children aged six months to five years, and three doses of Pfizer’s shots for those between six months and four years old. […]

Continue Reading →

US panel weighs authorizing Covid vaccines for youngest children

WASHINGTON, United States (AFP) — After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation’s youngest children. Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal […]

Continue Reading →

Moderna seeks US authorization for Covid vaccine in children under 6: statement

  WASHINGTON, United States (AFP) — US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years. Children under six are the only age group that has yet to gain access to a Covid-19 vaccine in the United States and in most countries. “We believe (this vaccine) will be able to safely protect […]

Continue Reading →

Moderna Covid vaccine gets full US approval

WASHINGTON, United States (AFP) — The US Food and Drug Administration (FDA) announced Monday that it has granted full approval to Moderna’s Covid-19 “Spikevax” vaccine, which had previously received an emergency use authorization in the United States. “The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” acting FDA commissioner Janet Woodcock said in a statement. […]

Continue Reading →

Tests of HIV vaccine using mRNA technology have begun

WASHINGTON, United States (AFP) — Testing in humans of an HIV vaccine that uses messenger RNA technology has begun, the biotech firm Moderna and the International AIDS Vaccine Initiative said Thursday. This Phase 1 trial is being carried out in the United States among 56 healthy adults who are HIV negative. Despite four decades of research, doctors have yet to develop a vaccine to protect people from the virus that causes AIDS, which kills hundreds […]

Continue Reading →

Moderna begins trial of Omicron-specific vaccine booster

WASHINGTON, United States (AFP) — US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus. The trials will involve a total of 600 adults — half of whom have already received two doses of Moderna’s Covid-19 vaccine at least six months ago, and half of whom have received two doses plus the previously authorized booster dose. […]

Continue Reading →

Pfizer/BioNTech to develop mRNA-based shingles shot

BERLIN, Germany (AFP) – Germany’s BioNTech and US pharma giant Pfizer, which together developed a Covid-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology. Moderna meanwhile announced it had dosed its first volunteer for a vaccine against Epstein–Barr virus (EBV), the cause of mononucleosis. The three companies are leveraging the same mRNA technology they used to develop highly successful Covid-19 vaccines towards other diseases, in […]

Continue Reading →

Moderna confident that booster works against Omicron

WASHINGTON, United States (AFP) — US vaccine maker Moderna expressed confidence Monday that its booster shot was effective against the Omicron variant, after the announcement of laboratory results it described as “reassuring.” “We’ll be able to rely on this vaccine to address the near term surge of Omicron cases,” Stephen Hoge, president of Moderna, said on a conference call. However he said tests showed that after only two doses, protection against Omicron was “substantially lower” […]

Continue Reading →
1 2 3 … 8